| Financial Year |
March 31 2023 |
| Monetary Funds |
125,635,220.11 |
| Held-for-trading Financial Assets |
11,932,398.01 |
| Notes Receivable |
33,114,597.14 |
| Accounts Receivable |
619,535,025.20 |
| Advances to Suppliers |
11,771,746.94 |
| Other Receivables |
11,417,121.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
399,499,309.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,038,732.81 |
| Total Current Assets |
1,291,050,386.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
325,998.33 |
| Fixed Assetes |
1,075,928,617.22 |
| Under-construction Projects |
329,405,618.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
168,635,962.55 |
| R&D expenses |
-- |
| Goodwill |
451,129,288.41 |
| Long-Term Deferred and Prepaid Expenses |
72,694,713.46 |
| Deferred Income Tax Assets |
80,585,693.95 |
| Other Non-Current Assets |
45,907,912.30 |
| Sub-Total of Non-Current Assets |
2,253,146,958.88 |
| Total Assets |
3,544,197,345.24 |
| Short-Term Loans |
483,823,786.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
270,604,741.61 |
| Accounts Payable |
608,137,003.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,858,309.01 |
| Taxes Payable |
8,555,435.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
118,945,981.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,080,462.37 |
| Other Current Liabilities |
1,079,732.18 |
| Sub-Total of Current Liabilities |
1,599,391,085.37 |
| Long-term Loans |
394,259,405.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,372,148.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
425,271,690.86 |
| Total Liabilities |
2,024,662,776.23 |
| Paid-In Capital(Or Share Stock) |
326,322,560.00 |
| Capital Surplus |
634,397,664.43 |
| Surplus Reserve |
40,613,890.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
517,283,039.06 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,519,534,569.01 |
| Owner's Equity（Stockholder's Equity） |
1,519,534,569.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,544,197,345.24 |
